Clinical Trial Update: Assessment of Body, Liver and Labile Plasma Iron and Their Association With Outcome and Immunological Recovery in Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Stem Cell Transplantation - ALLIVE (ALLogeneic Iron inVEstigators) Observational Trial

View source ↗

Summary

An observational study (ALLIVE) completed that evaluated body, liver, and labile plasma iron metrics and their associations with clinical outcomes and immunolog…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Snippet

Sponsor: GWT-TUD GmbH | Conditions: MDS and AML Prior to Allogeneic SCT | Status: COMPLETED